Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Proteomics data for: Pan-Apoptotic Protein Signature as a Novel Diagnostic and Prognostic Biomarker for Intracerebral Hemorrhage

ABSTRACT: Intracerebral hemorrhage (ICH) remains a major cause of morbidity and mortality, with no rapid blood-based biomarkers available to assess secondary brain injury. This study aimed to identify a circulating pan-cell death protein signature for diagnosing and prognosing ICH. We prospectively enrolled 60 ICH patients and 60 age/sex-matched healthy controls, collecting plasma at defined time points after ICH onset. Using Olink® proteomics, we identified 13 apoptosis-related proteins with significant dysregulation. Four key proteins—TLR4, ALOX15, FTL, and BMF—were validated through ELISA and RT-qPCR, showing good diagnostic performance (AUCs 0.799–0.835). A multi-protein logistic model demonstrated excellent diagnostic accuracy (AUC = 0.955). These biomarkers correlated with clinical severity and prognosis, including hematoma volume and 90-day modified Rankin Scale (mRS). Additionally, animal models confirmed time-dependent upregulation of TLR4 in astrocytes. This pan-cell death protein signature provides valuable insights into ICH pathology and offers a promising tool for early diagnosis, risk stratification, and therapeutic targeting.

ORGANISM(S): Homo Sapiens

SUBMITTER: Nan Zhao

PROVIDER: PXD071856 | iProX | Thu Dec 11 00:00:00 GMT 2025

REPOSITORIES: iProX

ACCESS DATA

Json Xml

Similar Datasets

Leukocyte dynamics after intracerebral hemorrhage in a living patient reveal rapid adaptations to tissue milieu

Project description:Intracerebral hemorrhage (ICH) is a devastating form of stroke with a high mortality rate and few treatment options. Discovery of therapeutic interventions has been slow given the challenges associated with studying acute injury, particularly over time, in the human brain. Inflammation induced by exposure of brain tissue to blood appears to be a major part of brain tissue injury. Here we longitudinally profiled blood and cerebral hematoma effluent from a patient enrolled in the Minimally Invasive Surgery with Thrombolysis in Intracerebral Haemorrhage Evacuation (MISTIEIII) trial, offering a rare window into the local and systemic immune responses to acute brain injury. Using single-cell RNA-sequencing, we characterized the local cellular response during ICH in the brain of a living patient at single-cell resolution for the first time. Our analysis revealed rapid shifts in the activation states of myeloid and T cells in the brain over time, suggesting that leukocyte responses are dynamically reshaped by the hematoma microenvironment. Interestingly, the patient had an asymptomatic re-bleed (second local exposure to blood) that our transcriptional data indicated occurred more than 30 hours prior to detection by CT scan. This case highlights the rapid immune dynamics in the brain after ICH and suggests that sensitive methods like scRNA-seq can inform our understanding of complex intracerebral events.

2021-06-02 | GSE166638 | GEO

Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma with Lead-Time Trajectory in Pre-Diagnostic Samples

Project description:Background & Aims: Early detection biomarkers for pancreatic ductal adenocarcinoma (PDAC) are needed since the clinically validated biomarker, CA19-9, has limited sensitivity and specificity for early-stage disease. Circulating miRNAs in plasma associated with cancer relevant pathways were developed as early detection biomarkers. Methods: Whole transcriptome assay interrogated 2,083 miRNAs in 15 µl of plasma from multicenter diagnostic cohorts (N=203: controls, n=82; diagnosed PDAC cases: n=121) and a pre-diagnostic PLCO cohort (N=96; controls, n=48; pre-diagnosed cases, n=48). A three-miRNA biomarker signature was developed for early detection of PDAC. Results: The three-miRNA signature detected PDAC from healthy controls independently (AUC = 0.974) and in combination with CA19-9 (AUC = 0.995). It also discriminated from pancreatitis (AUC = 0.931), improving performance of CA19-9 alone (AUC = 0.749) in combination (AUC = 0.954). Blinded validation in pre-diagnostic PLCO cohort revealed lead-time trajectory increase in AUC to 0.702 tat twelve-months before PDAC diagnosis. Conclusions: Plasma miRNAs associated with oncogenic pathways may serve as PDAC early detection biomarkers, with model performance progressively increasing approximately twelve months before diagnosis.

2026-01-14 | GSE259327 | GEO

Circulating microRNA signatures for diagnosis and prediction of progression in pediatric idiopathic scoliosis

Project description:Introduction: Idiopathic scoliosis (IS) is the most common pediatric spinal deformity, yet no biomarker currently enables early diagnosis or reliable prediction of progression to guide individualized treatment. Circulating microRNAs (miRNAs) are promising non-invasive biomarkers reflecting multifactorial disease mechanisms. Methods: We conducted a prospective study in a Czech cohort comprising 114 pediatric IS patients at the time of diagnosis (82 females, 32 males; median age 13 years, range 7–17) and 89 age-matched healthy controls (60 females, 29 males; median age 13 years, range 7–18). Plasma miRNA profiles were obtained by next-generation sequencing, corrected for batch effect, and analyzed for differential expression. Logistic regression models were used to construct miRNA diagnostic and prognostic signatures, validated by leave-one-out cross-validation (LOOCV). Differential expression analysis identified multiple miRNAs with significant diagnostic potential. A 28-miRNA diagnostic signature distinguished IS patients from controls with AUC = 0.95 and LOOCV accuracy = 0.85, with high PPV and NPV. For prognosis, comparison of high-risk versus low/medium-risk patients revealed a 7-miRNA prognostic signature, achieving AUC = 0.83 and LOOCV accuracy = 0.81. Notably, the incorporation of clinical variables such as age or sex did not improve model performance. Our study demonstrates that circulating miRNA signatures have potential as diagnostic markers and, importantly, as predictors of disease progression in pediatric idiopathic scoliosis. These findings highlight the clinical utility of miRNA-based models for individualized patient management and support further validation in larger, independent cohorts.

2026-02-11 | GSE308158 | GEO

Characterization of large extracellular vesicles released by apoptotic and pyroptotic cells

Project description:Extracellular vesicles (EVs) are emerging key factors maintaining cellular homeostasis, critical mediators of intercellular communication, potential biomarkers and therapeutic tools. While small EVs have been extensively characterized, the molecular signatures of large EVs (including those generated during regulated cell death pathways) remain poorly defined. Here, we investigated the characteristics of large EVs released during apoptosis and pyroptosis by human monocytic cell lines (THP-1 and U937). Apoptosis was induced by staurosporine and blocked with the pan-caspase inhibitor Q-VD-OPh, whereas pyroptosis was triggered by LPS/nigericin and inhibited with a selective NLRP3 inhibitor. We found that both forms of regulated cell death markedly enhanced the release of large EVs. Both apoptotic and pyroptotic large EVs showed increased Annexin V binding and decreased CD9 expression as compared to those released by healthy living cells. Apoptosis- and pyroptosis-derived large EVs exhibited distinct proteomic profiles. Pyroptotic large EVs were shown to contain interacting protein networks of RNA binding proteins and chromatin-associated proteins many of which are known as established damage associated molecular patterns or alarmins. On the other hand, we found that a subpopulation of apoptotic large EVs was characterized by the presence of dsDNA, and active caspase-3/7. Together, our data shed light on the specific protein content of large EVs released by cells undergoing apoptosis and pyroptosis. This study identifies candidate markers of large EVs released by dying cells and may enhance our understanding of the role of EVs in cell death.

2026-01-08 | MSV000100407 | MassIVE

Plasma glycoproteomic profiling characterization of glycosylation biomarkers for HCC diagnosis

Project description:Hepatocellular carcinoma (HCC) is a life-threatening disease. Due to the lack of reliable diagnostic biomarkers, the diagnosis of this disease is challenging. Recently, plasma glycoproteomics has emerged as a powerful tool for the identifying disease diagnostic biomarkers. Here, we performed a comprehensive proteomic and glycoproteomic analysis in the plasma of 12 HCC patients and 12 healthy control (HC) individuals. We identified 20 signature proteins and 32 signature IGPs that can distinguish HCC from HC effectively. Moreover, we demonstrated that IGPs profiles could be better predictive biomarkers for screening HCC than protein profiles. Pathways for signature proteins and IGPs were illustrated. For the first time, we showed that the protein expression level of LGALS3BP, as well as its N-linked glycosylation at the N511/398 sites could be a valuable diagnosis biomarker of HCC. Overall, our data suggest a major role for glycoproteomics in understanding HCC, and presents a number of new biomarkers for future

2023-05-09 | PXD039745 |

circRNA-sequencing analysis of plasma exosomes in hepatocellular carcinoma

Project description:Hepatocellular carcinoma (HCC) is currently the third leading cause of death worldwide and the most common type of primary liver cancer, finding noninvasive biomarkers for HCC diagnostic and prognostic are very urging. Previous genomic studies mainly focus on finding miRNA biomarkers for HCC. In this study, we focus on finding circRNA fragments suitable for serving as hcc biomarkers with plasma exosomal RNA-seq..

2021-12-01 | GSE164953 | GEO

RNAseq data of blood samples from hospitalized children with viral and bacterial pneumonia used to validate the novel 5-transcript signature that differentiates bacterial from viral pneumonia

Project description:Pneumonia remains the leading cause of death in children under five, but existing diagnostic methods frequently lead to either insufficient or excessive treatments. Our study aims to bridge this gap by identifying host transcriptomic biomarkers in the blood of children with confirmed viral or bacterial pneumonia. Using RNA sequencing, we identified and validated in an independent cohort a 5-transcript signature that accurately differentiates bacterial from viral pneumonia. This signature has considerable potential to improve diagnostic accuracy for pediatric pneumonia, minimizing delays in diagnosis and avoiding unnecessary treatments, with the possibility of significantly impacting clinical practice. a strand specific library preparation was completed using NEBNext® Ultra™ II mRNA kit (NEB) and NEB rRNA/globin depletion probes following manufacturer’s recommendations. Individual libraries were normalized using Qubit, pooled together and diluted. The sequencing was performed using a 150 paired-end configuration in a Novaseq6000 platform. Quality control of raw data was carried out using FastQC, alignment and read counting were performed using STAR, alignment filtering was done with SAMtools and read counting was carried out using FeatureCounts. RNAseq data was processed for batch correction using control samples and COMBAT-Seq package.

2024-12-08 | E-MTAB-14564 | biostudies-arrayexpress

Combinatorial blood platelets-derived circRNA and mRNA signature for early-stage lung cancer

Project description:Despite the diversity of liquid biopsy transcriptomic repertoire, numerous studies often 30 exploit only a single RNA type signature for diagnostic biomarker potential. This frequently results 31 in insufficient sensitivity and specificity necessary to reach diagnostic utility. Combinatorial biomarker approaches may offer a more reliable diagnosis. Here we investigated the synergistic contributions of circRNA and mRNA signatures derived from blood platelets as biomarkers for lung cancer detection. We developed a comprehensive bioinformatics pipeline permitting analysis of platelet-circRNA and mRNA derived from non-cancer individuals and lung cancer patients. An optimal selected signature is then used to generate the predictive classification model using machine learning algorithm. Using an individual signature of 21 circRNA and 28 mRNA, the predictive models reached an Area Under the Curve (AUC) of 0.88 and 0.81, respectively. Importantly, combinatorial analysis including both types of RNAs resulted in an 8-target signature (6 mRNA and 2 40 circRNA) enhancing the differentiation of lung cancer from controls (AUC of 0.92). Additionally, we identified five biomarkers potentially specific for early-stage detection of lung cancer. Our proof-of-concept study presents the first multi-analyte-based approach for the analysis of platelets-derived biomarkers, providing a potential combinatorial diagnostic signature for lung cancer detection.

2023-06-23 | GSE225787 | GEO

RNA-seq analysis of hepatocellular carcinoma plasma

Project description:Hepatocellular carcinoma (HCC) is currently the third leading cause of death worldwide and the most common type of primary liver cancer, finding noninvasive biomarkers for HCC diagnostic and prognostic are very urging. Previous genomic studies mainly focus on finding miRNA biomarkers for HCC. In this study, we focus on finding long noncoding RNA fragments suitable for serving as hcc biomarkers with plasma and exosomal RNA-seq

2020-06-14 | GSE123972 | GEO

Proteomic insights into the pathogenesis of intracerebral hemorrhage: The role of blend sign in hematoma expansion

Project description:The blend sign on CT imaging is a key predictor of hematoma growth in intracerebral hemorrhage (ICH), yet the underlying pathological mechanisms remain poorly understood. To address this, hematoma specimens from nine ICH patients with blend signs were collected via stereotactic minimally invasive puncture, targeting both high-density and low-density bleeding regions. Proteins were extracted and analyzed using isotope-labeled iTRAQ-based quantitative proteomics combined with LC-MS/MS. Bioinformatic analysis identified differentially expressed proteins, associated pathways, and regulatory microRNAs, followed by validation with Western blotting and ELISA. A total of 72 differentially expressed proteins were identified, with enrichment in processes including inflammation, apoptosis, oxidative stress, and metabolism. Key molecules such as cytochrome C, growth-associated protein 43, and tau were significantly upregulated in high-density regions. Integration with microRNA prediction suggested regulatory interactions, and drug screening highlighted potential therapeutic candidates such as dexketoprofen and 2-mercaptoethanesulfonic acid. This dataset provides raw mass spectrometry files and processed quantification results, offering a valuable resource for exploring the molecular basis of hematoma expansion and for identifying potential biomarkers and therapeutic targets in ICH.

2025-08-21 | PXD067588 |

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data